(Total Views: 329)
Posted On: 03/01/2022 12:35:53 PM
Post# of 70
$DRRX News Article - DURECT Corporation Doses First European Patient in Phase 2b AHFIRM Study of Larsucosterol(DUR-928) in Severe Alcohol-Associated Hepatitis https://marketwirenews.com/news-releases/dure...53171.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼
